UCLB supports venture capital firm MTI to target new investment fund
Published on Thursday 9 February 2012
The Orion fund is being launched in a partnership between UCLB,
MTI and the technology transfer offices of the Universities of Manchester and
Edinburgh.
UCLB will work alongside UMI3 of the University of
Manchester and ERI from the University of Edinburgh to identify investment...
more
Pentraxin Therapeutics founder is awarded a knighthood
Published on Thursday 5 January 2012
UCLB 2011 Award winner, Professor
Sir Mark Pepys was knighted for services to Biomedicine in this year's New
Years Honour 2012 list.
Professor Pepys
is the founder of Pentraxin Therapeutics Ltd, a UCL spinout company which
focuses on the treatment of amyloidosis and the Director of the...
more
Gene therapy treatment of haemophilia
Published on Friday 16 December 2011
The recent publication by UCL (Professor Amit Nathwani), St Judes Children’s hospital and the Royal Free Hospital in the New England Journal of Medicine describes how a single infusion of this Factor IX treatment consistently leads to long-term expression of the missing protein. This missing...
more
UCLB Agrees Exclusive Licence Deal With The Linde Group
Published on Tuesday 15 November 2011
UCLB has agreed an exclusive licence with the world-leading gases and engineering company The Linde Group for a process to separate and purify single-wall nanotubes. Single-wall carbon nanotubes (SWNTs) offer excellent electronic and mechanical properties, making them suitable for a vast range of...
more